Enanta Pharmaceuticals (ENTA) Change in Taxes (2014 - 2026)
Enanta Pharmaceuticals (ENTA) reported Change in Taxes of $19000.0 for Q1 2026, down 98.64% on a YoY basis from $1.4 million in Q1 2025, and down 99.97% quarter-over-quarter from $65.8 million in Q3 2025.
Enanta Pharmaceuticals (ENTA) Change in Taxes (2014 - 2026) Analysis & Trends
Enanta Pharmaceuticals has reported Change in Taxes for 13 years, with the latest figure at $19000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Taxes fell 98.64% year-over-year to $19000.0; the trailing twelve-month figure through Mar 2026 stood at $32.0 million (up 1671.02% YoY), and the FY2025 full-year result was $33.8 million, up 3295.48% from the prior year.
- Change in Taxes for Q1 2026 stood at $19000.0, down from $65.8 million in the prior quarter.
- The five-year high for Change in Taxes was $65.8 million in Q3 2025, with the low at -$33.8 million in Q2 2025.
- Historically, Change in Taxes has averaged $2.3 million across 5 years, with a median of $45000.0 in 2023.
- The largest YoY upside for Change in Taxes was 50970.0% in 2023 against a maximum downside of 14185.0% in 2023.
- Enanta Pharmaceuticals' Change in Taxes stood at -$15000.0 in 2022, then jumped by 4966.67% to $730000.0 in 2023, then sank by 39.04% to $445000.0 in 2024, then jumped by 14677.53% to $65.8 million in 2025, then tumbled by 99.97% to $19000.0 in 2026.
- The last three Change in Taxes figures came in at $19000.0 (Q1 2026), $65.8 million (Q3 2025), and -$33.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 343.24 Mn | 179.46 Mn | - | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,000.00 |
| Mar 31, 2026 | 19,000.00 |
| Sep 30, 2025 | 65.76 Mn |
| Sep 30, 2025 | 65.76 Mn |
| Jun 30, 2025 | -33.81 Mn |
| Jun 30, 2025 | -33.81 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 445,000.00 |
| Dec 31, 2024 | 445,000.00 |
| Sep 30, 2024 | -456,000.00 |
| Sep 30, 2024 | -456,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 297,000.00 |
| Mar 31, 2024 | 297,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Sep 30, 2023 | 5.09 Mn |
| Sep 30, 2023 | 5.09 Mn |